AVDL
Avadel Pharmaceuticals
AVDL
AVDL
44 hedge funds and large institutions have $80.6M invested in Avadel Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
2% less funds holding
Funds holding: 45 → 44 (-1)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Holders
44
Holding in Top 10
2
Calls
$655K
Puts
$239K
Top Buyers
| 1 | +$1.54M | |
| 2 | +$715K | |
| 3 | +$505K | |
| 4 |
Millennium Management
New York
|
+$494K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$393K |
Top Sellers
| 1 | -$2.5M | |
| 2 | -$859K | |
| 3 | -$137K | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$130K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$83.5K |